A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent

PHASE4CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Acute Mountain Sickness
Interventions
DRUG

Acetazolamide

125 mg twice daily until 4380 meters altitude

DRUG

Placebo

Twice daily

Trial Locations (1)

Unknown

Oxford University Clinical Research Unit Nepal, Kathmandu

All Listed Sponsors
collaborator

University of Oxford

OTHER

collaborator

Wellcome Trust

OTHER

collaborator

Mountain Medicine Society of Nepal

OTHER

lead

Oxford University Clinical Research Unit, Vietnam

OTHER

NCT01418157 - A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent | Biotech Hunter | Biotech Hunter